Sadly because there is no definitive treatment for SARS Covid-19 we are reaching for straws. The study quoted had too few patients to be statistically significant. HCQ does show antiviral activity for HIV when combined with other specific anti-HIV drugs. HCQ is not benign. There are dose related effects and for doses greater than 400 mg daily the side effects are significant including possible permanent blindness. The trials will take many weeks and it’s difficult to design trials for mildly symptomatic patients. The Chinese physicians found no difference in ICU admission or mortality but HCQ was added late in the course. For now, hold your horses.
P.S. I just retired from 37 years of medicine with direct patient contact and the last 28 years were Emergency Medicine.
P.S. I just retired from 37 years of medicine with direct patient contact and the last 28 years were Emergency Medicine.